1	Effect	Effect	B-NP	NN	O	0	ROOT	0
2	of	of	B-PP	IN	O	1	NMOD	-1
3	platelet-rich	platelet-rich	B-NP	JJ	O	4	NMOD	-1
4	plasma	plasma	I-NP	NN	O	7	NMOD	-1
5	and	and	I-NP	CC	O	7	NMOD	-1
6	fibrin	fibrin	I-NP	NN	O	7	NMOD	-1
7	glue	glue	I-NP	NN	O	2	PMOD	-1
8	on	on	B-PP	IN	O	1	NMOD	-1
9	healing	healing	B-NP	NN	O	8	PMOD	-1
10	of	of	B-PP	IN	O	9	NMOD	-1
11	critical-size	critical-size	B-NP	JJ	O	14	NMOD	-1
12	calvarial	calvarial	I-NP	JJ	O	14	NMOD	-1
13	bone	bone	I-NP	NN	O	14	NMOD	-1
14	defects	defect	I-NP	NNS	O	10	PMOD	0
15	.	.	O	.	O	1	P	-1

1	Despite	Despite	B-PP	IN	O	20	VMOD	-1
2	the	the	B-NP	DT	O	4	NMOD	-1
3	insufficient	insufficient	I-NP	JJ	O	4	NMOD	-1
4	number	number	I-NP	NN	O	1	PMOD	-1
5	of	of	B-PP	IN	O	4	NMOD	-1
6	experimental	experimental	B-NP	JJ	O	7	NMOD	-1
7	studies	study	I-NP	NNS	O	5	PMOD	-1
8	,	,	O	,	O	20	P	-1
9	platelet-rich	platelet-rich	B-NP	JJ	O	10	NMOD	-1
10	plasma	plasma	I-NP	NN	O	20	SUB	-1
11	(	(	O	(	O	13	DEP	-1
12	PRP	PRP	B-NP	NN	B-protein	13	DEP	-1
13	)	)	O	)	O	10	NMOD	-1
14	including	include	B-PP	VBG	O	10	NMOD	-1
15	high	high	B-NP	JJ	O	16	NMOD	-1
16	amounts	amount	I-NP	NNS	O	14	PMOD	-1
17	of	of	B-PP	IN	O	16	NMOD	-1
18	growth	growth	B-NP	NN	B-protein	19	NMOD	0
19	factors	factor	I-NP	NNS	I-protein	17	PMOD	-1
20	is	be	B-VP	VBZ	O	0	ROOT	-1
21	introduced	introduce	I-VP	VBN	O	20	VC	-1
22	to	to	B-PP	TO	O	21	VMOD	-1
23	clinical	clinical	B-NP	JJ	O	24	NMOD	-1
24	use	use	I-NP	NN	O	22	PMOD	0
25	rapidly	rapidly	B-ADVP	RB	O	24	NMOD	-1
26	.	.	O	.	O	20	P	-1

1	The	The	B-NP	DT	O	2	NMOD	-1
2	aim	aim	I-NP	NN	O	6	SUB	-1
3	of	of	B-PP	IN	O	2	NMOD	-1
4	this	this	B-NP	DT	O	5	NMOD	-1
5	study	study	I-NP	NN	O	3	PMOD	-1
6	was	be	B-VP	VBD	O	0	ROOT	-1
7	to	to	B-VP	TO	O	8	VMOD	-1
8	compare	compare	I-VP	VB	O	30	VMOD	-1
9	the	the	B-NP	DT	O	10	NMOD	-1
10	effects	effect	I-NP	NNS	O	8	OBJ	16	effects
11	of	of	B-PP	IN	O	10	NMOD	-1
12	PRP	PRP	B-NP	NN	B-protein	15	NMOD	-1
13	and	and	O	CC	O	15	NMOD	-1
14	platelet-poor	platelet-poor	B-NP	JJ	O	15	NMOD	-1
15	plasma	plasma	I-NP	NN	O	11	PMOD	-1
16	(	(	O	(	O	18	DEP	-1
17	PPP	PPP	B-NP	NN	B-protein	18	DEP	-1
18	)	)	O	)	O	15	NMOD	-1
19	on	on	B-PP	IN	O	10	NMOD	-1
20	healing	healing	B-NP	NN	O	19	PMOD	-1
21	of	of	B-PP	IN	O	20	NMOD	-1
22	critical-size	critical-size	B-NP	JJ	O	25	NMOD	-1
23	bone	bone	I-NP	NN	O	25	NMOD	-1
24	defects.Bilateral	defects.Bilateral	I-NP	JJ	O	25	NMOD	-1
25	full-thickness	full-thickness	I-NP	NN	O	21	PMOD	-1
26	,	,	O	,	O	8	P	-1
27	critical-size	critical-size	B-NP	JJ	O	29	NMOD	-1
28	bone	bone	I-NP	NN	O	29	NMOD	-1
29	defects	defect	I-NP	NNS	O	30	SUB	0
30	were	be	B-VP	VBD	O	6	VMOD	-1
31	created	create	I-VP	VBN	O	30	VC	-1
32	in	in	B-PP	IN	O	31	VMOD	-1
33	the	the	B-NP	DT	O	35	NMOD	-1
34	parietal	parietal	I-NP	JJ	O	35	NMOD	-1
35	bones	bone	I-NP	NNS	O	32	PMOD	-1
36	of	of	B-PP	IN	O	35	NMOD	-1
37	32	32	B-NP	CD	O	38	NMOD	-1
38	rabbits	rabbit	I-NP	NNS	O	36	PMOD	-1
39	,	,	O	,	O	30	P	-1
40	which	which	B-NP	WDT	O	30	VMOD	-1
41	had	have	B-VP	VBD	O	40	SBAR	-1
42	been	be	I-VP	VBN	O	41	VC	-1
43	studied	study	I-VP	VBN	O	42	VC	-1
44	in	in	B-PP	IN	O	43	VMOD	-1
45	4	4	B-NP	CD	O	46	NMOD	-1
46	groups	group	I-NP	NNS	O	44	PMOD	-1
47	.	.	O	.	O	6	P	-1

1	Saline	Saline	B-NP	NN	O	9	NMOD	-1
2	,	,	O	,	O	9	P	-1
3	thrombin	thrombin	B-NP	NN	B-protein	4	NMOD	-1
4	solution	solution	I-NP	NN	O	9	NMOD	-1
5	,	,	O	,	O	9	P	-1
6	PPP	PPP	B-NP	NN	B-protein	9	NMOD	-1
7	,	,	O	,	O	9	P	-1
8	and	and	O	CC	O	9	NMOD	-1
9	PRP	PRP	B-NP	NN	B-protein	10	SUB	-1
10	were	be	B-VP	VBD	O	0	ROOT	-1
11	applied	apply	I-VP	VBN	O	10	VC	19	applied
12	to	to	B-PP	TO	O	11	VMOD	-1
13	the	the	B-NP	DT	O	15	NMOD	-1
14	created	create	I-NP	VBN	O	15	NMOD	-1
15	defects	defect	I-NP	NNS	O	12	PMOD	0
16	before	before	B-PP	IN	O	11	VMOD	-1
17	closure	closure	B-NP	NN	O	16	PMOD	0
18	.	.	O	.	O	10	P	-1

1	Radiologic	Radiologic	B-NP	JJ	O	4	NMOD	-1
2	defect	defect	I-NP	NN	O	4	NMOD	-1
3	area	area	I-NP	NN	O	4	NMOD	-1
4	measurement	measurement	I-NP	NN	O	5	SUB	-1
5	results	result	B-VP	VBZ	O	0	ROOT	0
6	at	at	B-PP	IN	O	5	VMOD	-1
7	0	0	B-NP	CD	O	14	VMOD	-1
8	,	,	I-NP	,	O	14	P	-1
9	4	4	I-NP	CD	O	14	SUB	-1
10	,	,	O	,	O	14	P	-1
11	and	and	O	CC	O	14	VMOD	-1
12	16	16	B-NP	CD	O	13	NMOD	-1
13	weeks	week	I-NP	NNS	O	14	SUB	-1
14	were	be	B-VP	VBD	O	6	SBAR	-1
15	compared	compare	I-VP	VBN	O	14	VC	-1
16	between	between	B-PP	IN	O	15	VMOD	-1
17	the	the	B-NP	DT	O	18	NMOD	-1
18	groups	group	I-NP	NNS	O	16	PMOD	-1
19	.	.	O	.	O	5	P	-1

1	In	In	B-PP	IN	O	13	VMOD	-1
2	addition	addition	B-NP	NN	O	1	PMOD	0
3	,	,	O	,	O	13	P	-1
4	densities	density	B-NP	NNS	O	13	SUB	-1
5	of	of	B-PP	IN	O	4	NMOD	-1
6	the	the	B-NP	DT	O	9	NMOD	-1
7	newly	newly	I-NP	RB	O	8	AMOD	-1
8	formed	form	I-NP	VBN	O	9	NMOD	2	formed
9	bones	bone	I-NP	NNS	O	5	PMOD	-1
10	at	at	B-PP	IN	O	4	NMOD	-1
11	16th	16th	B-NP	JJ	O	12	NMOD	-1
12	week	week	I-NP	NN	O	10	PMOD	-1
13	were	be	B-VP	VBD	O	0	ROOT	-1
14	studied	study	I-VP	VBN	O	13	VC	-1
15	.	.	O	.	O	13	P	-1

1	Histologic	Histologic	B-NP	JJ	O	2	NMOD	-1
2	parameters	parameter	I-NP	NNS	O	20	SUB	-1
3	(	(	O	(	O	19	DEP	-1
4	primary	primary	B-NP	JJ	O	18	NMOD	-1
5	and	and	I-NP	CC	O	18	NMOD	-1
6	secondary	secondary	I-NP	JJ	O	8	NMOD	-1
7	bone	bone	I-NP	NN	O	8	NMOD	-1
8	trabecula	trabecula	I-NP	NN	O	18	NMOD	-1
9	,	,	O	,	O	18	P	-1
10	neovascularization	neovascularization	B-NP	NN	O	18	NMOD	3	neovascularization
11	,	,	O	,	O	18	P	-1
12	and	and	O	CC	O	18	NMOD	-1
13	bone	bone	B-NP	NN	O	14	NMOD	-1
14	marrow	marrow	I-NP	NN	O	18	NMOD	-1
15	and	and	O	CC	O	18	NMOD	-1
16	connective	connective	B-NP	JJ	O	18	NMOD	-1
17	tissue	tissue	I-NP	NN	O	18	NMOD	-1
18	formation	formation	I-NP	NN	O	19	DEP	2	formation
19	)	)	O	)	O	2	NMOD	-1
20	were	be	B-VP	VBD	O	0	ROOT	-1
21	compared	compare	I-VP	VBN	O	20	VC	-1
22	between	between	B-PP	IN	O	21	VMOD	-1
23	4-	4-	B-NP	CD	O	28	NMOD	-1
24	and	and	O	CC	O	28	NMOD	-1
25	16-week	16-week	B-NP	JJ	O	28	NMOD	-1
26	groups.More	groups.More	I-NP	NN	O	28	NMOD	-1
27	rapid	rapid	I-NP	JJ	O	28	NMOD	-1
28	decrease	decrease	I-NP	NN	O	22	PMOD	0
29	in	in	B-PP	IN	O	28	NMOD	-1
30	defect	defect	B-NP	NN	O	31	NMOD	-1
31	size	size	I-NP	NN	O	29	PMOD	-1
32	was	be	B-VP	VBD	O	20	VMOD	-1
33	observed	observe	I-VP	VBN	O	32	VC	0
34	in	in	B-PP	IN	O	33	VMOD	-1
35	groups	group	B-NP	NNS	O	34	PMOD	-1
36	3	3	B-NP	CD	O	35	NMOD	-1
37	and	and	I-NP	CC	O	35	NMOD	-1
38	4	4	I-NP	CD	O	35	NMOD	-1
39	than	than	B-PP	IN	O	32	VMOD	-1
40	in	in	B-PP	IN	O	39	PMOD	-1
41	groups	group	B-NP	NNS	O	40	PMOD	-1
42	1	1	I-NP	CD	O	41	NMOD	-1
43	and	and	I-NP	CC	O	41	NMOD	-1
44	2	2	I-NP	CD	O	41	NMOD	-1
45	,	,	O	,	O	32	P	-1
46	both	both	O	CC	O	32	VMOD	-1
47	in	in	B-PP	IN	O	46	PMOD	-1
48	the	the	B-NP	DT	O	52	NMOD	-1
49	4th	4th	I-NP	JJ	O	52	NMOD	-1
50	and	and	I-NP	CC	O	52	NMOD	-1
51	16th	16th	I-NP	JJ	O	52	NMOD	-1
52	weeks	week	I-NP	NNS	O	47	PMOD	-1
53	.	.	O	.	O	20	P	-1

1	Newly	Newly	B-NP	RB	O	2	AMOD	-1
2	formed	form	I-NP	VBN	O	4	NMOD	2	formed
3	bone	bone	I-NP	NN	O	4	NMOD	-1
4	densities	density	I-NP	NNS	O	5	SUB	-1
5	were	be	B-VP	VBD	O	0	ROOT	-1
6	also	also	I-VP	RB	O	5	VMOD	-1
7	found	find	I-VP	VBN	O	5	VC	0
8	to	to	I-VP	TO	O	9	VMOD	-1
9	be	be	I-VP	VB	O	7	VMOD	-1
10	higher	high	B-ADJP	JJR	O	9	PRD	-1
11	in	in	B-PP	IN	O	10	AMOD	-1
12	these	these	B-NP	DT	O	14	NMOD	-1
13	2	2	I-NP	CD	O	14	NMOD	-1
14	groups	group	I-NP	NNS	O	11	PMOD	-1
15	.	.	O	.	O	5	P	-1

1	New	New	B-NP	JJ	O	3	NMOD	-1
2	bone	bone	I-NP	NN	O	3	NMOD	-1
3	formation	formation	I-NP	NN	O	4	SUB	2	formation
4	was	be	B-VP	VBD	O	0	ROOT	-1
5	detected	detect	I-VP	VBN	O	4	VC	0
6	to	to	I-VP	TO	O	7	VMOD	-1
7	be	be	I-VP	VB	O	5	VMOD	-1
8	more	more	B-ADJP	RBR	O	9	AMOD	-1
9	rapid	rapid	I-ADJP	JJ	O	7	PRD	-1
10	considering	consider	B-VP	VBG	O	7	VMOD	-1
11	histologic	histologic	B-NP	JJ	O	12	NMOD	-1
12	parameters	parameter	I-NP	NNS	O	10	OBJ	-1
13	,	,	O	,	O	4	P	-1
14	in	in	B-PP	IN	O	4	VMOD	-1
15	groups	group	B-NP	NNS	O	14	PMOD	-1
16	3	3	B-NP	CD	O	15	NMOD	-1
17	and	and	I-NP	CC	O	15	NMOD	-1
18	4	4	I-NP	CD	O	15	NMOD	-1
19	at	at	B-PP	IN	O	4	VMOD	-1
20	4th	4th	B-NP	JJ	O	23	NMOD	-1
21	and	and	I-NP	CC	O	23	NMOD	-1
22	16th	16th	I-NP	JJ	O	23	NMOD	-1
23	weeks.Study	weeks.Study	I-NP	NN	O	19	PMOD	-1
24	demonstrates	demonstrate	B-VP	VBZ	O	4	VMOD	-1
25	that	that	B-SBAR	IN	O	24	VMOD	-1
26	PRP	PRP	B-NP	NN	B-protein	28	NMOD	-1
27	and	and	I-NP	CC	O	28	NMOD	-1
28	PPP	PPP	I-NP	NN	B-protein	29	SUB	-1
29	might	might	B-VP	MD	O	25	SBAR	-1
30	have	have	I-VP	VB	O	29	VC	-1
31	favorable	favorable	B-NP	JJ	O	32	NMOD	-1
32	effects	effect	I-NP	NNS	O	30	OBJ	16	effects
33	on	on	B-PP	IN	O	32	NMOD	-1
34	bone	bone	B-NP	NN	O	35	NMOD	-1
35	healing	healing	I-NP	NN	O	33	PMOD	-1
36	.	.	O	.	O	4	P	-1

1	Although	Although	B-SBAR	IN	O	0	ROOT	-1
2	we	we	B-NP	PRP	O	3	SUB	-1
3	can	can	B-VP	MD	O	1	SBAR	-1
4	not	not	I-VP	RB	O	3	VMOD	-1
5	reveal	reveal	I-VP	VB	O	3	VC	-1
6	any	any	B-NP	DT	O	8	NMOD	-1
7	statistical	statistical	I-NP	JJ	O	8	NMOD	-1
8	difference	difference	I-NP	NN	O	5	OBJ	-1
9	between	between	B-PP	IN	O	8	NMOD	-1
10	these	these	B-NP	DT	O	12	NMOD	-1
11	2	2	I-NP	CD	O	12	NMOD	-1
12	substances	substance	I-NP	NNS	O	9	PMOD	-1
13	considering	consider	B-VP	VBG	O	12	NMOD	-1
14	osteoinductive	osteoinductive	B-NP	JJ	O	15	NMOD	-1
15	potential	potential	I-NP	NN	O	18	NMOD	0
16	,	,	O	,	O	18	P	-1
17	PRP	PRP	B-NP	NN	B-protein	18	NMOD	-1
18	group	group	I-NP	NN	I-protein	13	OBJ	-1
19	has	have	B-VP	VBZ	O	1	DEP	-1
20	demonstrated	demonstrate	I-VP	VBN	O	19	VC	-1
21	superior	superior	B-NP	JJ	O	22	NMOD	-1
22	results	result	I-NP	NNS	O	20	OBJ	0
23	compared	compare	B-PP	VBN	O	20	VMOD	-1
24	with	with	B-PP	IN	O	23	PMOD	-1
25	fibrin	fibrin	B-NP	NN	O	27	NMOD	-1
26	glue	glue	I-NP	NN	O	27	NMOD	-1
27	group	group	I-NP	NN	O	24	PMOD	-1
28	.	.	O	.	O	1	P	-1

1	Higher	High	B-NP	JJR	O	3	NMOD	-1
2	platelet	platelet	I-NP	NN	O	3	NMOD	-1
3	concentrations	concentration	I-NP	NNS	O	4	SUB	-1
4	may	may	B-VP	MD	O	0	ROOT	-1
5	expose	expose	I-VP	VB	O	4	VC	-1
6	beneficial	beneficial	B-NP	JJ	O	7	NMOD	-1
7	effects	effect	I-NP	NNS	O	5	OBJ	0
8	of	of	B-PP	IN	O	7	NMOD	-1
9	PRP	PRP	B-NP	NN	B-protein	8	PMOD	-1
